nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—PTGS2—bile duct cancer	0.71	1	CbGaD
Cisplatin—MPO—superior mesenteric artery—bile duct cancer	0.0612	0.269	CbGeAlD
Cisplatin—ABCC3—bile duct—bile duct cancer	0.0219	0.0964	CbGeAlD
Cisplatin—ABCC2—bile duct—bile duct cancer	0.0175	0.077	CbGeAlD
Cisplatin—ABCC2—bile—bile duct cancer	0.0135	0.0592	CbGeAlD
Cisplatin—MT2A—gall bladder—bile duct cancer	0.0103	0.0453	CbGeAlD
Cisplatin—MT1A—pancreas—bile duct cancer	0.00571	0.0251	CbGeAlD
Cisplatin—NQO1—gall bladder—bile duct cancer	0.00522	0.0229	CbGeAlD
Cisplatin—ABCC3—gall bladder—bile duct cancer	0.00468	0.0206	CbGeAlD
Cisplatin—GSTP1—gall bladder—bile duct cancer	0.00466	0.0205	CbGeAlD
Cisplatin—MT1A—liver—bile duct cancer	0.00363	0.016	CbGeAlD
Cisplatin—SOD1—pancreas—bile duct cancer	0.00361	0.0158	CbGeAlD
Cisplatin—CYP4A11—liver—bile duct cancer	0.00335	0.0147	CbGeAlD
Cisplatin—ATP7B—liver—bile duct cancer	0.00326	0.0143	CbGeAlD
Cisplatin—MT2A—liver—bile duct cancer	0.00303	0.0133	CbGeAlD
Cisplatin—SLC31A2—liver—bile duct cancer	0.00297	0.0131	CbGeAlD
Cisplatin—GSTT1—liver—bile duct cancer	0.00296	0.013	CbGeAlD
Cisplatin—MT1A—lymph node—bile duct cancer	0.00279	0.0122	CbGeAlD
Cisplatin—ATP7A—liver—bile duct cancer	0.00262	0.0115	CbGeAlD
Cisplatin—ATP7B—lymph node—bile duct cancer	0.0025	0.011	CbGeAlD
Cisplatin—ABCC6—liver—bile duct cancer	0.0024	0.0106	CbGeAlD
Cisplatin—NQO1—pancreas—bile duct cancer	0.0024	0.0106	CbGeAlD
Cisplatin—SOD1—liver—bile duct cancer	0.00229	0.0101	CbGeAlD
Cisplatin—SLC31A2—lymph node—bile duct cancer	0.00228	0.01	CbGeAlD
Cisplatin—SLC31A1—liver—bile duct cancer	0.00224	0.00981	CbGeAlD
Cisplatin—MPO—pancreas—bile duct cancer	0.00221	0.0097	CbGeAlD
Cisplatin—XDH—liver—bile duct cancer	0.00221	0.00969	CbGeAlD
Cisplatin—GSTM1—liver—bile duct cancer	0.00218	0.00958	CbGeAlD
Cisplatin—PTGS2—gall bladder—bile duct cancer	0.00217	0.00955	CbGeAlD
Cisplatin—GSTP1—pancreas—bile duct cancer	0.00215	0.00943	CbGeAlD
Cisplatin—ATP7A—lymph node—bile duct cancer	0.00201	0.00882	CbGeAlD
Cisplatin—SOD1—lymph node—bile duct cancer	0.00176	0.00772	CbGeAlD
Cisplatin—SLC31A1—lymph node—bile duct cancer	0.00171	0.00752	CbGeAlD
Cisplatin—GSTM1—lymph node—bile duct cancer	0.00167	0.00734	CbGeAlD
Cisplatin—ABCC5—liver—bile duct cancer	0.00163	0.00718	CbGeAlD
Cisplatin—NQO1—liver—bile duct cancer	0.00153	0.00671	CbGeAlD
Cisplatin—MPO—liver—bile duct cancer	0.00141	0.00617	CbGeAlD
Cisplatin—ABCC3—liver—bile duct cancer	0.00137	0.00603	CbGeAlD
Cisplatin—GSTP1—liver—bile duct cancer	0.00137	0.006	CbGeAlD
Cisplatin—ABCC5—lymph node—bile duct cancer	0.00125	0.0055	CbGeAlD
Cisplatin—NQO1—lymph node—bile duct cancer	0.00117	0.00515	CbGeAlD
Cisplatin—ABCC2—liver—bile duct cancer	0.0011	0.00481	CbGeAlD
Cisplatin—MPO—lymph node—bile duct cancer	0.00108	0.00473	CbGeAlD
Cisplatin—ABCC3—lymph node—bile duct cancer	0.00105	0.00462	CbGeAlD
Cisplatin—GSTP1—lymph node—bile duct cancer	0.00105	0.0046	CbGeAlD
Cisplatin—PTGS2—pancreas—bile duct cancer	0.001	0.0044	CbGeAlD
Cisplatin—ABCC2—lymph node—bile duct cancer	0.000841	0.00369	CbGeAlD
Cisplatin—BCHE—liver—bile duct cancer	0.000827	0.00363	CbGeAlD
Cisplatin—ABCG2—liver—bile duct cancer	0.0008	0.00351	CbGeAlD
Cisplatin—CYP2B6—liver—bile duct cancer	0.000738	0.00324	CbGeAlD
Cisplatin—CYP2C9—liver—bile duct cancer	0.000731	0.00321	CbGeAlD
Cisplatin—PTGS2—liver—bile duct cancer	0.000638	0.0028	CbGeAlD
Cisplatin—BCHE—lymph node—bile duct cancer	0.000634	0.00279	CbGeAlD
Cisplatin—ABCB1—pancreas—bile duct cancer	0.00062	0.00272	CbGeAlD
Cisplatin—ABCG2—lymph node—bile duct cancer	0.000613	0.00269	CbGeAlD
Cisplatin—PTGS2—lymph node—bile duct cancer	0.000489	0.00215	CbGeAlD
Cisplatin—ABCB1—liver—bile duct cancer	0.000394	0.00173	CbGeAlD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000322	0.00519	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00032	0.00516	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00032	0.00515	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000318	0.00512	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—NRAS—bile duct cancer	0.000312	0.00503	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—TGFBR2—bile duct cancer	0.000308	0.00495	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000307	0.00495	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000307	0.00495	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000306	0.00494	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	0.000304	0.00489	CbGpPWpGaD
Cisplatin—ABCB1—lymph node—bile duct cancer	0.000302	0.00133	CbGeAlD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000301	0.00486	CbGpPWpGaD
Cisplatin—SOD1—Platelet degranulation—TGFB1—bile duct cancer	0.000294	0.00474	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000293	0.00472	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000287	0.00463	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—FAR2—bile duct cancer	0.000284	0.00458	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—HGF—bile duct cancer	0.000283	0.00455	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—TP53—bile duct cancer	0.000282	0.00455	CbGpPWpGaD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.00028	0.00451	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—FAR2—bile duct cancer	0.000277	0.00447	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000277	0.00446	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—KRAS—bile duct cancer	0.000269	0.00433	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—NRAS—bile duct cancer	0.000265	0.00428	CbGpPWpGaD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000265	0.00427	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—TGFBR2—bile duct cancer	0.000261	0.00421	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IL6—bile duct cancer	0.000258	0.00416	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—SLC5A5—bile duct cancer	0.000257	0.00415	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—IDH2—bile duct cancer	0.000254	0.00408	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000249	0.00401	CbGpPWpGaD
Cisplatin—XDH—Metabolism—FAR2—bile duct cancer	0.000249	0.00401	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TP53—bile duct cancer	0.000246	0.00397	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—HGF—bile duct cancer	0.00024	0.00387	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.00024	0.00386	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000239	0.00384	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000239	0.00384	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—FAR2—bile duct cancer	0.000238	0.00384	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—KRAS—bile duct cancer	0.000228	0.00368	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—HRAS—bile duct cancer	0.000228	0.00368	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL6—bile duct cancer	0.000225	0.00363	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—IDH1—bile duct cancer	0.000218	0.00351	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000208	0.00334	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFBR2—bile duct cancer	0.000207	0.00334	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—FAR2—bile duct cancer	0.000207	0.00333	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IL6—bile duct cancer	0.000205	0.00331	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—IL6—bile duct cancer	0.000198	0.00319	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000195	0.00314	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—HRAS—bile duct cancer	0.000194	0.00313	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—HGF—bile duct cancer	0.00019	0.00307	CbGpPWpGaD
Cisplatin—GSTM1—NRF2 pathway—TGFB1—bile duct cancer	0.000186	0.003	CbGpPWpGaD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000183	0.00294	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—NRAS—bile duct cancer	0.000181	0.00292	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—IL6—bile duct cancer	0.000179	0.00288	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—FAR2—bile duct cancer	0.000176	0.00283	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000174	0.0028	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—GNAS—bile duct cancer	0.000173	0.00279	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000166	0.00267	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HGF—bile duct cancer	0.000165	0.00266	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—IDH2—bile duct cancer	0.000163	0.00263	CbGpPWpGaD
Cisplatin—GSTP1—NRF2 pathway—TGFB1—bile duct cancer	0.000159	0.00255	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—IL6—bile duct cancer	0.000157	0.00252	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.000156	0.00251	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—TP53—bile duct cancer	0.000155	0.00249	CbGpPWpGaD
Cisplatin—NQO1—NRF2 pathway—TGFB1—bile duct cancer	0.000154	0.00249	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MUC4—bile duct cancer	0.000154	0.00247	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MUC1—bile duct cancer	0.000154	0.00247	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—SLC5A5—bile duct cancer	0.000144	0.00232	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—IL6—bile duct cancer	0.000142	0.00228	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000141	0.00227	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—IDH1—bile duct cancer	0.00014	0.00226	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00014	0.00225	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00014	0.00225	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RNF43—bile duct cancer	0.000139	0.00224	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—IDH2—bile duct cancer	0.000139	0.00224	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000137	0.00221	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—IDH2—bile duct cancer	0.000135	0.00218	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HGF—bile duct cancer	0.000135	0.00218	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—FAR2—bile duct cancer	0.000134	0.00216	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	0.000133	0.00214	CbGpPWpGaD
Cisplatin—ABCC5—NRF2 pathway—TGFB1—bile duct cancer	0.000133	0.00214	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HRAS—bile duct cancer	0.000133	0.00214	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.00013	0.0021	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.00013	0.00209	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000127	0.00205	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL6—bile duct cancer	0.000127	0.00205	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000127	0.00204	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NOS2—bile duct cancer	0.000126	0.00204	CbGpPWpGaD
Cisplatin—XDH—Metabolism—IDH2—bile duct cancer	0.000121	0.00196	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—FAR2—bile duct cancer	0.000121	0.00195	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00012	0.00194	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—FAR2—bile duct cancer	0.00012	0.00193	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IDH1—bile duct cancer	0.00012	0.00193	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—IDH1—bile duct cancer	0.000119	0.00192	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—IDH1—bile duct cancer	0.000116	0.00188	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—IDH2—bile duct cancer	0.000116	0.00188	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MUC2—bile duct cancer	0.000116	0.00187	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—TGFB1—bile duct cancer	0.000115	0.00186	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—NOS2—bile duct cancer	0.000115	0.00185	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—GNAS—bile duct cancer	0.000112	0.0018	CbGpPWpGaD
Cisplatin—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000111	0.00179	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00011	0.00176	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000105	0.00169	CbGpPWpGaD
Cisplatin—XDH—Metabolism—IDH1—bile duct cancer	0.000104	0.00168	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000104	0.00167	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000102	0.00165	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—IDH2—bile duct cancer	0.000101	0.00163	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—IDH1—bile duct cancer	0.0001	0.00161	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—TGFB1—bile duct cancer	9.79e-05	0.00158	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—bile duct cancer	9.31e-05	0.0015	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—SLC5A5—bile duct cancer	9.27e-05	0.00149	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—FAR2—bile duct cancer	9.24e-05	0.00149	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—FAR2—bile duct cancer	8.88e-05	0.00143	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	8.71e-05	0.0014	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—IDH1—bile duct cancer	8.68e-05	0.0014	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	8.62e-05	0.00139	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—IDH2—bile duct cancer	8.58e-05	0.00138	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL6—bile duct cancer	8.52e-05	0.00137	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	8.24e-05	0.00133	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—bile duct cancer	8.12e-05	0.00131	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—GNAS—bile duct cancer	8.08e-05	0.0013	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—SLC5A5—bile duct cancer	7.88e-05	0.00127	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ERBB2—bile duct cancer	7.79e-05	0.00125	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	7.76e-05	0.00125	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—SLC5A5—bile duct cancer	7.68e-05	0.00124	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	7.44e-05	0.0012	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL6—bile duct cancer	7.44e-05	0.0012	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	7.42e-05	0.0012	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	7.41e-05	0.00119	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—IDH1—bile duct cancer	7.38e-05	0.00119	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NRAS—bile duct cancer	7.23e-05	0.00117	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GNAS—bile duct cancer	7.2e-05	0.00116	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	7.17e-05	0.00115	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	7.09e-05	0.00114	CbGpPWpGaD
Cisplatin—XDH—Metabolism—SLC5A5—bile duct cancer	6.89e-05	0.00111	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TGFB1—bile duct cancer	6.72e-05	0.00108	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—SLC5A5—bile duct cancer	6.6e-05	0.00106	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—IDH2—bile duct cancer	6.56e-05	0.00106	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—FAR2—bile duct cancer	6.55e-05	0.00106	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	6.4e-05	0.00103	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFBR2—bile duct cancer	6.35e-05	0.00102	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	6.31e-05	0.00102	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KRAS—bile duct cancer	6.23e-05	0.001	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GNAS—bile duct cancer	6.12e-05	0.000986	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FAR2—bile duct cancer	6.12e-05	0.000986	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	6.11e-05	0.000984	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SMAD4—bile duct cancer	6.01e-05	0.000969	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—bile duct cancer	6e-05	0.000967	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	5.99e-05	0.000964	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GNAS—bile duct cancer	5.97e-05	0.000961	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	5.97e-05	0.000961	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—bile duct cancer	5.92e-05	0.000954	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—IDH2—bile duct cancer	5.92e-05	0.000953	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	5.88e-05	0.000947	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—IDH2—bile duct cancer	5.86e-05	0.000943	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	5.82e-05	0.000937	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	5.77e-05	0.00093	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—SLC5A5—bile duct cancer	5.73e-05	0.000922	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—IDH1—bile duct cancer	5.64e-05	0.000908	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	5.57e-05	0.000897	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—bile duct cancer	5.53e-05	0.000891	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	5.51e-05	0.000888	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—bile duct cancer	5.4e-05	0.000869	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RNF43—bile duct cancer	5.39e-05	0.000868	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	5.37e-05	0.000864	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GNAS—bile duct cancer	5.35e-05	0.000862	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—bile duct cancer	5.29e-05	0.000852	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GNAS—bile duct cancer	5.13e-05	0.000827	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KRAS—bile duct cancer	5.1e-05	0.000821	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—IDH1—bile duct cancer	5.09e-05	0.00082	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—IDH1—bile duct cancer	5.04e-05	0.000811	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	5.03e-05	0.00081	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SLC5A5—bile duct cancer	4.87e-05	0.000784	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IDH1—bile duct cancer	4.63e-05	0.000746	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	4.6e-05	0.000741	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—bile duct cancer	4.58e-05	0.000738	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.56e-05	0.000735	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—IDH2—bile duct cancer	4.51e-05	0.000727	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOS2—bile duct cancer	4.48e-05	0.000721	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GNAS—bile duct cancer	4.45e-05	0.000717	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—IDH2—bile duct cancer	4.34e-05	0.000699	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—bile duct cancer	4.33e-05	0.000698	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	4.17e-05	0.000671	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	4.15e-05	0.000669	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—bile duct cancer	4.15e-05	0.000668	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—bile duct cancer	4.09e-05	0.000659	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	4.07e-05	0.000656	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	4.07e-05	0.000656	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—IDH1—bile duct cancer	3.88e-05	0.000625	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.88e-05	0.000624	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—bile duct cancer	3.87e-05	0.000623	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.85e-05	0.00062	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GNAS—bile duct cancer	3.78e-05	0.000609	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—IDH1—bile duct cancer	3.73e-05	0.000601	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC5A5—bile duct cancer	3.72e-05	0.000599	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP2—bile duct cancer	3.52e-05	0.000566	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—bile duct cancer	3.51e-05	0.000565	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	3.49e-05	0.000561	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.42e-05	0.000551	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—bile duct cancer	3.37e-05	0.000542	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC5A5—bile duct cancer	3.36e-05	0.000541	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC5A5—bile duct cancer	3.32e-05	0.000535	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—bile duct cancer	3.29e-05	0.00053	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—bile duct cancer	3.29e-05	0.00053	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—bile duct cancer	3.21e-05	0.000516	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—IDH2—bile duct cancer	3.2e-05	0.000515	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—bile duct cancer	3.13e-05	0.000505	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.01e-05	0.000485	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—IDH2—bile duct cancer	2.99e-05	0.000481	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.94e-05	0.000474	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GNAS—bile duct cancer	2.89e-05	0.000466	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	2.89e-05	0.000465	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—bile duct cancer	2.87e-05	0.000463	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—bile duct cancer	2.76e-05	0.000444	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—IDH1—bile duct cancer	2.75e-05	0.000443	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	2.73e-05	0.000439	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GNAS—bile duct cancer	2.61e-05	0.00042	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GNAS—bile duct cancer	2.58e-05	0.000416	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—IDH1—bile duct cancer	2.57e-05	0.000414	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—bile duct cancer	2.56e-05	0.000412	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC5A5—bile duct cancer	2.56e-05	0.000412	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFBR2—bile duct cancer	2.46e-05	0.000397	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC5A5—bile duct cancer	2.46e-05	0.000396	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	2.42e-05	0.00039	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—bile duct cancer	2.39e-05	0.000385	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—bile duct cancer	2.38e-05	0.000383	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—bile duct cancer	2.33e-05	0.000376	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SMAD4—bile duct cancer	2.33e-05	0.000376	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—bile duct cancer	2.2e-05	0.000355	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—bile duct cancer	2.03e-05	0.000327	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNAS—bile duct cancer	1.99e-05	0.00032	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNAS—bile duct cancer	1.91e-05	0.000308	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—bile duct cancer	1.87e-05	0.000302	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—bile duct cancer	1.81e-05	0.000292	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—bile duct cancer	1.79e-05	0.000289	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS2—bile duct cancer	1.74e-05	0.000279	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—bile duct cancer	1.7e-05	0.000273	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.59e-05	0.000256	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—bile duct cancer	1.55e-05	0.00025	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNAS—bile duct cancer	1.41e-05	0.000227	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—bile duct cancer	1.4e-05	0.000226	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—bile duct cancer	1.39e-05	0.000223	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNAS—bile duct cancer	1.32e-05	0.000212	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—bile duct cancer	1.3e-05	0.00021	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—bile duct cancer	1.03e-05	0.000165	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—bile duct cancer	9.93e-06	0.00016	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—bile duct cancer	9.22e-06	0.000149	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—bile duct cancer	9.04e-06	0.000146	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—bile duct cancer	8.54e-06	0.000138	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—bile duct cancer	7.57e-06	0.000122	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—bile duct cancer	7.26e-06	0.000117	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—bile duct cancer	7.08e-06	0.000114	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—bile duct cancer	6.95e-06	0.000112	CbGpPWpGaD
